This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Timbrell, J.A. Articles by Wright, J.M. Search for Related Content PubMed Articles by Timbrell, J.A. Articles by Wright, J.M. Social Bookmarking                         What's this?

Urinary Metabolic Profile of Isoniazid in Patients who Develop Isoniazid-related Liver Damage

Clinical Toxicology Unit, Clinical Pharmacology Department, Royal Postgraduate Medical School, London, UK

J.M. Wright

Department of Pharmacology and Medicine, University of British Colombia, Vancouver, Canada

1 The urinary metabolite profile of isoniazid has been studied in patients receiving the drug as therapy for tuberculosis and the profile in patients suffering liver damage due to isoniazid compared with that in control patients.

2 There were no consistent differences between control patients and those suffering liver damage in the excretion of isoniazid metabolites.

3 It may be that susceptibility to the hepatotoxicity of isoniazid is not due to metabolic differences, although a number of other possible explanations are discussed.

4 It is not at present possible to predict which patients will be susceptible from metabolic studies.

Human & Experimental Toxicology, Vol. 3, No. 6, 485-495 (1984)
DOI: 10.1177/096032718400300603


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?